医药生物行业周报：中报披露期继续优选确定性成长个股

DONGXING SECURITIES 敬请参阅报告结尾处的免责声明 东方财智 兴盛之源 行业研究 东兴证券股份有限公司证券研究报告 DONGXING SECURITIES 东兴证券行业周报（20170724-20170730） 生物医药行业：中报披露继续优选确定性成长个股 P3 敬请参阅报告结尾处的免责声明 东方财智 兴盛之源 1. ............................................................................................................................................................................... 4 1.1 ........................................................................................................................................................................................ 4 1.1.1 ............................................................................................................................................................. 4 1.1.2 ..................................................................................................................................................... 7 1.1.3 ..................................................................................................................................................................... 8 1.2 ......................................................................................................................................................................................10 1.2.1 ...........................................................................................................................................................10 1.2.2 ........................................................................................................................................................... 11 1.3 ..............................................................................................................................................................................13 2. .........................................................................................................................................................................................15 2.1 ..................................................................................................................................................................................15 2.2 ......................................................................................................................................................................................19 2.3 ..................................................................................................................................................................................19 3. .........................................................................................................................................................................................21 4. .....................................................................................................................................................................................23 4.1 ..................................................................................................................................................23 5. .................................................................................................................................................................................................26 P4 东兴证券行业周报（20170814-20170820） 生物医药行业：中报披露继续优选确定性成长个股 DONGXING SECURITIES 敬请参阅报告结尾处的免责声明 东方财智 兴盛之源 1: ........................................................................................................................................................... 9 2: ........................................................................................................................................................... 9 3: .................................................................................................................................................21 1:2017vs.300vs......................................................................................... 5 2:2017 ................................................................................................. 5 3:%........................................................................................................ 6 4:%............................................................................................ 6 5:%................................................................................................................................................ 7 6:%............................................................................................................................................ 8 7:TTM .............................................................................................................................10 8:vs.A ..............................................................10 9:vs.A .................................................. 11 10:TTM ...................................................................................................................12 11:TTM .............................................................................